Phase II trial of cabazitaxel in patients with advanced or metastatic transitional cell carcinoma of the urothelial tract who have progressed within less than 12 months after cisplatin-based chemotherapy: A Spanish Oncology Genitourinary Group (SOGUG) study.
Jose Angel Arranz Arija
Honoraria - Sanofi
Research Funding - Sanofi
Miguel Angel Climent Duran
Honoraria - Sanofi
Research Funding - Sanofi
Albert Font Pous
No relevant relationships to disclose
Mirta Garcia Alonso
No relevant relationships to disclose
Enrique Gallardo Diaz
No relevant relationships to disclose
Xavier Garcia del Muro
No relevant relationships to disclose
Aranzazu Gonzalez del Alba
No relevant relationships to disclose
Nuria Lainez Milagro
No relevant relationships to disclose
Martin Lázaro Quintela
No relevant relationships to disclose
Marta F. López-Brea
No relevant relationships to disclose
M Pilar Lopez Criado
No relevant relationships to disclose
Raquel Luque Caro
No relevant relationships to disclose
Cristina Martin Lorente
No relevant relationships to disclose
Maria Jose Mendez Vidal
No relevant relationships to disclose
Alvaro Pinto Marin
No relevant relationships to disclose
M.I. Saez
No relevant relationships to disclose
Carmen Santander Lobera
No relevant relationships to disclose
Sergio Vazquez Estévez
No relevant relationships to disclose
Juan Virizuela Echaburu
No relevant relationships to disclose
Ignacio Duran
No relevant relationships to disclose